Open Access

Adipocyte size in morbidly obese women and its relation to type 2 diabetes


Cite

1. Bambace C, Telesca M, Zoico E, Sepe A, Olioso D, Rossi A, Corzato F, Di Francesco V, Mazzucco A, Santini F, Zamboni M. Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011;20(5):e153-6. Search in Google Scholar

2. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92(3):1023-33. Search in Google Scholar

3. Kunath A, Klöting N. Adipocyte biology and obesity-mediated adipose tissue remodeling. Obesity Medicine 2016; 4:15-20. Search in Google Scholar

4. Lafontan M. Adipose tissue and adipocyte dysregulation. Diabetes Metab 2014;40(1):16-28. Search in Google Scholar

5. O'Connell J, Lynch L, Cawood TJ, Kwasnik A, Nolan N, Geoghegan J, McCormick A, O'Farrelly C, O'Shea D. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One 2010;5(4):e9997. Search in Google Scholar

6. Lönn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2010;24(1):326-31. Search in Google Scholar

7. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000;43(12):1498-506. Search in Google Scholar

8. McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, Cushman SW, Sherman A. Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 2010;53(2):369-77. Search in Google Scholar

9. Fang L, Guo F, Zhou L, Stahl R, Grams J. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte 2015;4(4):273-9. Search in Google Scholar

10. Laforest S, Michaud A, Paris G, Pelletier M, Vidal H, Géloën A, Tchernof A. Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk. Obesity (Silver Spring) 2017;25(1):122-131. Search in Google Scholar

11. Michaud A, Laforest S, Pelletier M, Nadeau M, Simard S, Daris M, Lebœuf M, Vidal H, Géloën A, Tchernof A. Abdominal adipocyte populations in women with visceral obesity. Eur J Endocrinol 2016;174(2):227-39. Search in Google Scholar

12. Lessard J, Laforest S, Pelletier M, Leboeuf M, Blackburn L, Tchernof A. Low abdominal subcutaneous preadipocyte adipogenesis is associated with visceral obesity, visceral adipocyte hypertrophy, and a dysmetabolic state. Adipocyte 2014;3(3):197-205. Search in Google Scholar

13. Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6(3):343-68. Search in Google Scholar

14. Hoffstedt J, Arner E, Wahrenberg H, Andersson DP, Qvisth V, Löfgren P, Rydén M, Thörne A, Wirén M, Palmér M, Thorell A, Toft E, Arner P. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 2010;53(12):2496-503. Search in Google Scholar

15. Garaulet M, Hernandez-Morante JJ, Lujan J, Tebar FJ, Zamora S. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in over-weight/obese humans. Int J Obes (Lond) 2006;30(6):899-905. Search in Google Scholar

16. Pope BD, Warren CR, Parker KK, Cowan CA. Microenvironmental Control of Adipocyte Fate and Function. Trends Cell Biol 2016;26(10):745-755. Search in Google Scholar

17. Grigoraş A, Amalinei C, Balan RA, Giuşcă SE, Avădănei ER, Lozneanu L, Căruntu ID. Adipocytes spectrum – From homeostasia to obesity and its associated pathology. Ann Anat 2018;219:102-120. Search in Google Scholar

18. Monteiro R, de Castro PM, Calhau C, Azevedo I. Adipocyte size and liability to cell death. Obes Surg 2006;16(6):804-6. Search in Google Scholar

19. Murphy J, Moullec G, Santosa S. Factors associated with adipocyte size reduction after weight loss interventions for overweight and obesity: a systematic review and meta-regression. Metabolism 2017;67:31-40. Search in Google Scholar

20. Löfgren P1, Andersson I, Adolfsson B, Leijonhufvud BM, Hertel K, Hoffstedt J, Arner P. Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state. J Clin Endocrinol Metab 2005;90(11):6207-13. Search in Google Scholar

21. Bredella MA, Karastergiou K, Bos SA, Gerweck AV, Torriani M, Fried SK, Miller KK. GH administration decreases subcutaneous abdominal adipocyte size in men with abdominal obesity. Growth Horm IGF Res 2017;35:17-20. Search in Google Scholar

22. Pasarica M, Xie H, Hymel D, Bray G, Greenway F, Ravussin E, Smith SR. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009;32(5):900-2. Search in Google Scholar

eISSN:
1338-4139
Language:
English
Publication timeframe:
3 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Cardiology